Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

Well, if you're talking about the melanoma trial combo with Yervoy, they need to get it enrolled first. Based on the pace of the liver trial enrollment at the same single center with approximately the same number of patients, I'd say we're still about a year away from full enrollment.

Melanoma is crowded anyway. Makes no sense to get into that ring IMO.